期刊： ACTA ONCOLOGICA, 2023; 62 (6)
BackgroundNeuroendocrine neoplasms represent a diverse group of malignancies. Anatomic origin, histology and aggressiveness vary extensively, from low......
期刊： ACTA ONCOLOGICA, 2023; 62 (10)
Background: Fatigue is a distressing and prevalent long-term sequela of treatment for childhood cancer, and there is a need for longitudinal studies t......
期刊： ACTA ONCOLOGICA, 2023; 62 (12)
BackgroundOur previous study has revealed that EphA7 was upregulated in patient-derived esophageal squamous cell carcinoma (ESCC) xenografts with hype......
期刊： ACTA ONCOLOGICA, 2023; 62 (3)
AimOur goal was to describe a precision medicine program in a regional academic hospital, characterize features of included patients and present early......
期刊： ACTA ONCOLOGICA, 2023; 62 (2)
BackgroundCurrent guidelines in HER2-positive metastatic breast cancer (mBC) recommend the combination of trastuzumab and a chemotherapeutic agent for......
期刊： ACTA ONCOLOGICA, 2023; 62 (4)
AimTo investigate the pathological complete response (pCR) achieved after neoadjuvant therapy with versus without adding pertuzumab (P) to trastuzumab......
期刊： ACTA ONCOLOGICA, 2023; 62 (6)
BackgroundWe aimed to evaluate the correlation of apoprotein E (APOE) transcription and its methylation with immune microenvironment in HCC patients.M......
期刊： ACTA ONCOLOGICA, 2023; 62 (9)
BackgroundPrevious studies have shown that a large proportion of relapses in head-and neck squamous cell carcinoma (HNSCC) following radiotherapy (RT)......
期刊： ACTA ONCOLOGICA, 2023; 62 (8)
BackgroundLife expectancy for patients diagnosed with metastatic breast cancer (BC) has improved in recent years, especially due to better systemic tr......
期刊： ACTA ONCOLOGICA, 2023; 62 (9)
BackgroundSymptoms of posttraumatic stress disorder (PTSD) and adjustment disorder (AjD) are common in hematological cancer patients as they face seve......
期刊： ACTA ONCOLOGICA, 2023; 62 (8)
BackgroundThis study investigates whether inequalities in the utilization of resection and/or ablation for synchronous colorectal liver metastases (SC......
期刊： ACTA ONCOLOGICA, 2023; 62 (10)
Background: Evidence on the risk of second primary cancer (SPC) following primary laryngeal squamous cell carcinoma (LSCC) is limited, especially in E......
